| Alison Renee Platukis, CNM | |
|
600 Fitch St Ste 102, Elmira, NY 14905-1634 | |
| (607) 734-6544 | |
| (607) 734-6580 |
| Full Name | Alison Renee Platukis |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 600 Fitch St Ste 102, Elmira, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649811274 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 001965 (New York) | Primary |
| Entity Name | Guthrie Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134178635 PECOS PAC ID: 6002728656 Enrollment ID: O20031103000220 |
News Archive
Contrary to common thinking, cocaine triggers an addiction only in 20% of the consumers. But what happens in their brains when they lose control of their consumption? Thanks to a recent experimental method, neuroscientists at the University of Geneva, Switzerland, have revealed a brain mechanism specific to cocaine, which has the particularity of triggering a massive increase in serotonin in addition to the increase in dopamine common to all drugs.
Cepheid today announced it has received clearance from the U.S. Food & Drug Administration (FDA) to market Xpert® SA Nasal Complete, the first and only molecular test designed for the simultaneous detection and differentiation of both Staphylococcus aureus (SA) and Methicillin-resistant Staphylococcus aureus (MRSA) colonization in less than one hour. The test runs on Cepheid's GeneXpert® System, the world's leading molecular platform for accuracy, speed, and ease-of-use.
Merck & Co., Inc. today announced that, as of the close of business on August 13, 2010, the outstanding shares of the company's 6.00% Mandatory Convertible Preferred Stock will mandatorily convert by their terms into a right to receive cash and shares of Merck common stock.
Micronics, Inc., a development-stage company, today announced that the Department of Defense has awarded the company an Applied Research and Technology Development Award under the U.S. Army Medical Research and Materiel Command's Polytrauma and Blast Injury project for advancement of its PanNAT system for point-of-care molecular diagnosis of infectious pathogens.
Using a nicotine patch may help improve mild memory loss in older adults, according to a study published in the January 10, 2012, print issue of Neurology, the medical journal of the American Academy of Neurology.
› Verified 9 days ago
| Entity Name | Montefiore Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063525152 PECOS PAC ID: 3779496021 Enrollment ID: O20031113000235 |
News Archive
Contrary to common thinking, cocaine triggers an addiction only in 20% of the consumers. But what happens in their brains when they lose control of their consumption? Thanks to a recent experimental method, neuroscientists at the University of Geneva, Switzerland, have revealed a brain mechanism specific to cocaine, which has the particularity of triggering a massive increase in serotonin in addition to the increase in dopamine common to all drugs.
Cepheid today announced it has received clearance from the U.S. Food & Drug Administration (FDA) to market Xpert® SA Nasal Complete, the first and only molecular test designed for the simultaneous detection and differentiation of both Staphylococcus aureus (SA) and Methicillin-resistant Staphylococcus aureus (MRSA) colonization in less than one hour. The test runs on Cepheid's GeneXpert® System, the world's leading molecular platform for accuracy, speed, and ease-of-use.
Merck & Co., Inc. today announced that, as of the close of business on August 13, 2010, the outstanding shares of the company's 6.00% Mandatory Convertible Preferred Stock will mandatorily convert by their terms into a right to receive cash and shares of Merck common stock.
Micronics, Inc., a development-stage company, today announced that the Department of Defense has awarded the company an Applied Research and Technology Development Award under the U.S. Army Medical Research and Materiel Command's Polytrauma and Blast Injury project for advancement of its PanNAT system for point-of-care molecular diagnosis of infectious pathogens.
Using a nicotine patch may help improve mild memory loss in older adults, according to a study published in the January 10, 2012, print issue of Neurology, the medical journal of the American Academy of Neurology.
› Verified 9 days ago
| Entity Name | Strong Obstetrics-gynecology Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184668311 PECOS PAC ID: 2860382926 Enrollment ID: O20040319001257 |
News Archive
Contrary to common thinking, cocaine triggers an addiction only in 20% of the consumers. But what happens in their brains when they lose control of their consumption? Thanks to a recent experimental method, neuroscientists at the University of Geneva, Switzerland, have revealed a brain mechanism specific to cocaine, which has the particularity of triggering a massive increase in serotonin in addition to the increase in dopamine common to all drugs.
Cepheid today announced it has received clearance from the U.S. Food & Drug Administration (FDA) to market Xpert® SA Nasal Complete, the first and only molecular test designed for the simultaneous detection and differentiation of both Staphylococcus aureus (SA) and Methicillin-resistant Staphylococcus aureus (MRSA) colonization in less than one hour. The test runs on Cepheid's GeneXpert® System, the world's leading molecular platform for accuracy, speed, and ease-of-use.
Merck & Co., Inc. today announced that, as of the close of business on August 13, 2010, the outstanding shares of the company's 6.00% Mandatory Convertible Preferred Stock will mandatorily convert by their terms into a right to receive cash and shares of Merck common stock.
Micronics, Inc., a development-stage company, today announced that the Department of Defense has awarded the company an Applied Research and Technology Development Award under the U.S. Army Medical Research and Materiel Command's Polytrauma and Blast Injury project for advancement of its PanNAT system for point-of-care molecular diagnosis of infectious pathogens.
Using a nicotine patch may help improve mild memory loss in older adults, according to a study published in the January 10, 2012, print issue of Neurology, the medical journal of the American Academy of Neurology.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alison Renee Platukis, CNM 571 Saint Josephs Blvd Fl 2, Elmira, NY 14901-3230 Ph: (607) 271-2050 | Alison Renee Platukis, CNM 600 Fitch St Ste 102, Elmira, NY 14905-1634 Ph: (607) 734-6544 |
News Archive
Contrary to common thinking, cocaine triggers an addiction only in 20% of the consumers. But what happens in their brains when they lose control of their consumption? Thanks to a recent experimental method, neuroscientists at the University of Geneva, Switzerland, have revealed a brain mechanism specific to cocaine, which has the particularity of triggering a massive increase in serotonin in addition to the increase in dopamine common to all drugs.
Cepheid today announced it has received clearance from the U.S. Food & Drug Administration (FDA) to market Xpert® SA Nasal Complete, the first and only molecular test designed for the simultaneous detection and differentiation of both Staphylococcus aureus (SA) and Methicillin-resistant Staphylococcus aureus (MRSA) colonization in less than one hour. The test runs on Cepheid's GeneXpert® System, the world's leading molecular platform for accuracy, speed, and ease-of-use.
Merck & Co., Inc. today announced that, as of the close of business on August 13, 2010, the outstanding shares of the company's 6.00% Mandatory Convertible Preferred Stock will mandatorily convert by their terms into a right to receive cash and shares of Merck common stock.
Micronics, Inc., a development-stage company, today announced that the Department of Defense has awarded the company an Applied Research and Technology Development Award under the U.S. Army Medical Research and Materiel Command's Polytrauma and Blast Injury project for advancement of its PanNAT system for point-of-care molecular diagnosis of infectious pathogens.
Using a nicotine patch may help improve mild memory loss in older adults, according to a study published in the January 10, 2012, print issue of Neurology, the medical journal of the American Academy of Neurology.
› Verified 9 days ago
Deborah Wade, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 600 Fitch St, Suite 102, Elmira, NY 14905 Phone: 607-734-6544 Fax: 607-734-6580 | |
Katharine Cassidy-devito, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 600 Fitch St, Suite 206, Elmira, NY 14905 Phone: 607-732-1515 Fax: 607-732-2234 | |
Ms. Maggie G Kuch, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1005 Walnut St, Elmira, NY 14901 Phone: 607-734-3968 | |
Tamara Higgins, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 600 Fitch St, Elmira, NY 14905 Phone: 607-732-1515 | |
Esperanza Ducot, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 600 Ivy St, Elmira, NY 14905 Phone: 607-734-4191 Fax: 607-734-0026 | |
Glenda Hard, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 600 Fitch St., Suite 206, Elmira, NY 14905 Phone: 607-732-1515 Fax: 607-732-2234 |